Radiofrequency ablation for low-grade dysplasia in Barrett’s esophagus: long-term outcome of a randomized trial
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 92 (3) , 569-574
Abstract
No abstract availableKeywords
Funding Information
- Medtronic
This publication has 17 references indexed in Scilit:
- Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II)Gut, 2015
- Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registryGut, 2014
- Radiofrequency Ablation vs Endoscopic Surveillance for Patients With Barrett Esophagus and Low-Grade DysplasiaJAMA, 2014
- Efficacy and Durability of Radiofrequency Ablation for Barrett's Esophagus: Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2013
- Oesophageal carcinomaThe Lancet, 2013
- The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagusGastrointestinal Endoscopy, 2012
- Incidence of Adenocarcinoma among Patients with Barrett's EsophagusNew England Journal of Medicine, 2011
- American Gastroenterological Association Technical Review on the Management of Barrett's EsophagusGastroenterology, 2011
- Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trialGut, 2011
- Efficacy of Radiofrequency Ablation Combined With Endoscopic Resection for Barrett's Esophagus With Early NeoplasiaClinical Gastroenterology and Hepatology, 2010